A Swedish-Finnish study conducted between 2007-2014 found that vaccinating both girls and boys against HPV (a gender-neutral vaccination strategy) could lead to the eradication of the most common cancer-causing types of the virus through stronger herd immunity. The study randomized HPV vaccination interventions across 33 towns (gender neutral HPV, girls-only HPV, and a control non-HPV vaccination), including 80,000 adolescents between ages 12 and 15. Results of general HPV screening at the age of 19 showed that gender-neutral vaccination prevented HPV infections much more effectively than vaccinating girls only.
Full Citation:
Vänskä S, Luostarinen T, Baussano I et al.. 2020. Vaccination with moderate coverage eradicates oncogenic human papillomaviruses if a gender-neutral strategy is applied. The Journal of Infectious Diseases. 222(6).
Title of Article: Vaccination with moderate coverage eradicates oncogenic human papillomaviruses if a gender-neutral strategy is applied
Author(s): Vänskä S, Luostarinen T, Baussano I et al.
Publication Year: 2020
Publication Name: The Journal of Infectious Diseases
Publication Volume: 222(6)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/32161969/
DOI (Digital Object Identifier): 10.1093/infdis/jiaa099